Vicarious Surgical RBOT
OTC RBOT
$0.04 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Vicarious Surgical (RBOT) Amortization of Deferred Charges (2021 - 2022)

Vicarious Surgical (RBOT) posted quarterly Amortization of Deferred Charges of $50000.0 for Q4 2022, up 433.33% year-over-year from $9375.0 in Q4 2021, and up 525.0% quarter-over-quarter from $8000.0 in Q3 2022.

Vicarious Surgical (RBOT) Amortization of Deferred Charges (2021 - 2022) Analysis & Trends

Vicarious Surgical (RBOT) has reported Amortization of Deferred Charges for 2 consecutive years, with $50000.0 the latest figure, recorded in Q4 2022.

  • In Q4 2022, Amortization of Deferred Charges rose 433.33% year-over-year to $50000.0; the TTM figure through Dec 2022 stood at $75000.0 (changed N/A YoY), while the FY2022 annual figure was $75000.0, up 257.14% from the prior year.
  • Amortization of Deferred Charges climbed to $50000.0 in Q4 2022 per RBOT's latest filing, from $8000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $50000.0 in Q4 2022 and bottomed at -$15000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Vicarious Surgical 196,495.36 -14.84 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 50,000.00
Dec 31, 2022 50,000.00
Sep 30, 2022 8,000.00
Sep 30, 2022 8,000.00
Jun 30, 2022 9,000.00
Jun 30, 2022 9,000.00
Mar 31, 2022 8,000.00
Mar 31, 2022 8,000.00
Dec 31, 2021 -15,000.00
Dec 31, 2021 -15,000.00
Sep 30, 2021 27,000.00
Sep 30, 2021 27,000.00